Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Active, Not Recruiting

Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis

NCT04530318

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Hospital Moisés Broggi L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Clínic de Barcelona Barcelona, Spain
  • Hospital de Sant Pau Barcelona, Spain
View Trial Details
Active, Not Recruiting

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

NCT03500328

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • The University of South Alabama Mobile, Alabama, United States
  • St. Joseph's Hospital & Medical Center - Barrow Neurological Institute Phoenix, Arizona, United States
  • CommonSpirit Health Research Institute Carmichael, California, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

NCT03958877

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • UC San Diego Health La Jolla, California, United States
  • UNC Hospitals Chapel Hill, North Carolina, United States
  • Meridian Clinical Research Norfolk, Virginia, United States
  • Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
View all 65 locations
View Trial Details
Active, Not Recruiting

Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS

NCT03535298

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Colorado-Anschutz Medical Campus Aurora, Colorado, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

NCT04578639

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Nordlandsykehuset HF Bodø, Norway
  • Vestre Viken sykehus Drammen, Norway
  • Sørlandet Sykehus Kristiansand, Norway
View Trial Details

Related conditions